1. Home
  2. GEVO vs ETON Comparison

GEVO vs ETON Comparison

Compare GEVO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$2.34

Market Cap

568.2M

Sector

Industrials

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$24.96

Market Cap

510.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
ETON
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
568.2M
510.1M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
GEVO
ETON
Price
$2.34
$24.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.42
$39.33
AVG Volume (30 Days)
5.1M
416.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
58.82
N/A
EPS
N/A
N/A
Revenue
$711,000.00
$79,950,000.00
Revenue This Year
$19.44
$40.90
Revenue Next Year
$5.59
$47.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
104.94
52 Week Low
$0.95
$11.09
52 Week High
$2.97
$25.99

Technical Indicators

Market Signals
Indicator
GEVO
ETON
Relative Strength Index (RSI) 49.70 72.63
Support Level $2.25 $16.38
Resistance Level $2.46 N/A
Average True Range (ATR) 0.18 1.44
MACD -0.01 0.32
Stochastic Oscillator 8.78 86.43

Price Performance

Historical Comparison
GEVO
ETON

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: